BACKGROUND:Impedance cardiography (ICG) is a noninvasive modality that uses changes in impedance across the thorax to assess hemodynamic parameters, including cardiac output (CO). The utility of ICG in patients hospitalized with heart failure is uncertain. METHODS: The BioImpedance CardioGraphy in Advanced Heart Failure study was a prospective substudy of the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness. A total of 170 subjects underwent blinded ICG measurements using BioZ (CardioDynamics, San Diego, CA); of these, 82 underwent right heart catheterization. We compared ICG with invasively measured hemodynamics by simple correlation and compared overall ICG hemodynamic profiles ("wet" [thoracic fluid content > or =47/kOhm in men and > or =37/kOhm in women] and "cold" [cardiac index < or =2.2 L min(-1)m(-2)) versus those determined by invasive measurements (wet [pulmonary capillary wedge pressure > or =22 mm Hg] and cold [cardiac index < or =2.2 L min(-1)m(-2)). We also determined whether ICG measurements were associated with subsequent death or hospitalization within 6 months. RESULTS: There was modest correlation between ICG and invasively measured CO (r = 0.4 to 0.6 on serial measurement). Thoracic fluid content measured by ICG was not a reliable measure of pulmonary capillary wedge pressure. There was poor agreement between ICG and invasively measured hemodynamic profiles (kappa < or =0.1). No ICG variable alone or in combination was associated with outcome. CONCLUSIONS: In hospitalized patients with advanced heart failure, ICG provides some information about CO but not left-sided filling pressures. Impedance cardiography did not have prognostic utility in this patient population.
RCT Entities:
BACKGROUND: Impedance cardiography (ICG) is a noninvasive modality that uses changes in impedance across the thorax to assess hemodynamic parameters, including cardiac output (CO). The utility of ICG in patients hospitalized with heart failure is uncertain. METHODS: The BioImpedance CardioGraphy in Advanced Heart Failure study was a prospective substudy of the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness. A total of 170 subjects underwent blinded ICG measurements using BioZ (CardioDynamics, San Diego, CA); of these, 82 underwent right heart catheterization. We compared ICG with invasively measured hemodynamics by simple correlation and compared overall ICG hemodynamic profiles ("wet" [thoracic fluid content > or =47/kOhm in men and > or =37/kOhm in women] and "cold" [cardiac index < or =2.2 L min(-1)m(-2)) versus those determined by invasive measurements (wet [pulmonary capillary wedge pressure > or =22 mm Hg] and cold [cardiac index < or =2.2 L min(-1)m(-2)). We also determined whether ICG measurements were associated with subsequent death or hospitalization within 6 months. RESULTS: There was modest correlation between ICG and invasively measured CO (r = 0.4 to 0.6 on serial measurement). Thoracic fluid content measured by ICG was not a reliable measure of pulmonary capillary wedge pressure. There was poor agreement between ICG and invasively measured hemodynamic profiles (kappa < or =0.1). No ICG variable alone or in combination was associated with outcome. CONCLUSIONS: In hospitalized patients with advanced heart failure, ICG provides some information about CO but not left-sided filling pressures. Impedance cardiography did not have prognostic utility in this patient population.
Authors: M H Drazner; M A Hamilton; G Fonarow; J Creaser; C Flavell; L W Stevenson Journal: J Heart Lung Transplant Date: 1999-11 Impact factor: 10.247
Authors: Mark H Drazner; Brenda Thompson; Paul B Rosenberg; Patricia A Kaiser; James D Boehrer; Brian J Baldwin; Daniel L Dries; Clyde W Yancy Journal: Am J Cardiol Date: 2002-04-15 Impact factor: 2.778
Authors: Mark H Drazner; Anne S Hellkamp; Carl V Leier; Monica R Shah; Leslie W Miller; Stuart D Russell; James B Young; Robert M Califf; Anju Nohria Journal: Circ Heart Fail Date: 2008-09 Impact factor: 8.790
Authors: Cynthia Binanay; Robert M Califf; Vic Hasselblad; Christopher M O'Connor; Monica R Shah; George Sopko; Lynne W Stevenson; Gary S Francis; Carl V Leier; Leslie W Miller Journal: JAMA Date: 2005-10-05 Impact factor: 56.272
Authors: Yolanda Ballestero; Jesús López-Herce; Javier Urbano; Maria José Solana; Marta Botrán; Jose M Bellón; Angel Carrillo Journal: Pediatr Cardiol Date: 2011-02-13 Impact factor: 1.655
Authors: Hossam A Shaltout; Joel Eggebeen; Anthony P Marsh; Peter H Brubaker; Paul J Laurienti; Jonathan H Burdette; Swati Basu; Ashley Morgan; Patricia C Dos Santos; James L Norris; Timothy M Morgan; Gary D Miller; W Jack Rejeski; Amret T Hawfield; Debra I Diz; J Thomas Becton; Daniel B Kim-Shapiro; Dalane W Kitzman Journal: Nitric Oxide Date: 2017-05-23 Impact factor: 4.427
Authors: Sardar Ansari; Jessica R Golbus; Mohamad H Tiba; Brendan McCracken; Lu Wang; Keith D Aaronson; Kevin R Ward; Kayvan Najarian; Kenn R Oldham Journal: IEEE Sens J Date: 2020-11-03 Impact factor: 4.325
Authors: Sanchit Kumar; Angela M Victoria-Castro; Hannah Melchinger; Kyle D O'Connor; Mitchell Psotka; Nihar R Desai; Tariq Ahmad; F Perry Wilson Journal: J Cardiovasc Transl Res Date: 2022-09-09 Impact factor: 3.216
Authors: Michael Shochat; Avraham Shotan; David S Blondheim; Mark Kazatsker; Iris Dahan; Aya Asif; Ilia Shochat; Aaron Frimerman; Yoseph Rozenman; Simcha R Meisel Journal: J Clin Monit Comput Date: 2014-09-06 Impact factor: 2.502
Authors: Donald P Bernstein; Isaac C Henry; Harry J Lemmens; Janell L Chaltas; Anthony N DeMaria; James B Moon; Andrew M Kahn Journal: J Clin Monit Comput Date: 2015-02-15 Impact factor: 2.502
Authors: Saulius Sadauskas; Albinas Naudžiūnas; Alvydas Unikauskas; Edita Mašanauskienė; Giedrė Bakšytė; Andrius Macas Journal: Med Sci Monit Date: 2016-10-09